HIV-inhibitory natural products .30. Structure-activity modifications of the HIV-1 inhibitors (+)-calanolide A and (-)-calanolide B

被引:88
作者
Galinis, DL [1 ]
Fuller, RW [1 ]
McKee, TC [1 ]
Cardellina, JH [1 ]
Gulakowski, RJ [1 ]
McMahon, JB [1 ]
Boyd, MR [1 ]
机构
[1] NCI,LAB DRUG DISCOVERY RES & DEV,DEV THERAPEUT PROGRAM,DIV CANC TREATMENT DIAG & CTR,FREDERICK,MD 21702
关键词
D O I
10.1021/jm9602827
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The Delta(7,8) olefinic linkages within (+)-calanolide A (1) and (-)-calanolide B (2) were catalytically reduced to determine impact on the anti-HIV activity of the parent compounds. In addition, a series of structure modifications of the C-12 hydroxyl group in (-)-calanolide B was made to investigate the importance of that substituent to the HIV-1 inhibitory activity of these coumarins. A total of 14 analogs were isolated or prepared and compared to (+)-calanolide A and (-)-calanolide B in the NCI primary anti-HIV assay. While none of the compounds showed activity superior to the two unmodified leads, some structure-activity requirements were apparent from the relative anti-HIV potencies of the various analogs.
引用
收藏
页码:4507 / 4510
页数:4
相关论文
共 16 条
[1]   ANALYSIS OF NONNUCLEOSIDE DRUG-RESISTANT VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE [J].
BOYER, PL ;
CURRENS, MJ ;
MCMAHON, JB ;
BOYD, MR ;
HUGHES, SH .
JOURNAL OF VIROLOGY, 1993, 67 (04) :2412-2420
[2]   BIOLOGICAL AND BIOCHEMICAL ANTI-HIV ACTIVITY OF THE BENZOTHIADIAZINE CLASS OF NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITORS [J].
BUCKHEIT, RW ;
FLIAKASBOLTZ, V ;
DECKER, WD ;
ROBERSON, JL ;
PYLE, CA ;
WHITE, EL ;
BOWDEN, BJ ;
MCMAHON, JB ;
BOYD, MR ;
BADER, JP ;
NICKELL, DG ;
BARTH, H ;
ANTONUCCI, TK .
ANTIVIRAL RESEARCH, 1994, 25 (01) :43-56
[3]   RESOLUTION AND COMPARATIVE ANTI-HIV EVALUATION OF THE ENANTIOMERS OF CALANOLIDE-A AND CALANOLIDE-B [J].
CARDELLINA, JH ;
BOKESCH, HR ;
MCKEE, TC ;
BOYD, MR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (09) :1011-1014
[4]   TOTAL SYNTHESIS OF (PLUS-OR-MINUS)-CALANOLIDE-A, A NON-NUCLEOSIDE INHIBITOR OF HIV-1 REVERSE-TRANSCRIPTASE [J].
CHENERA, B ;
WEST, ML ;
FINKELSTEIN, JA ;
DREYER, GB .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (21) :5605-5606
[5]  
CURRENS MJ, IN PRESS J PHARM EXP
[6]  
DESHPANDE PP, 1995, SYNTHESIS-STUTTGART, P630
[7]   SYNTHESIS OF OPTICALLY-ACTIVE CALANOLIDE-A AND CALANOLIDE-B [J].
DESHPANDE, PP ;
TAGLIAFERRI, F ;
VICTORY, SF ;
YAN, SJ ;
BAKER, DC .
JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (10) :2964-2965
[8]   HIV-INHIBITORY COUMARINS FROM LATEX OF THE TROPICAL RAIN-FOREST TREE CALOPHYLLUM-TEYSMANNII VAR INOPHYLLOIDE [J].
FULLER, RW ;
BOKESCH, HR ;
GUSTAFSON, KR ;
MCKEE, TC ;
CARDELLINA, JH ;
MCMAHON, JB ;
CRAGG, GM ;
SOEJARTO, DD ;
BOYD, MR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (16) :1961-1964
[9]   LANTHANOIDS IN ORGANIC-SYNTHESIS .6. THE REDUCTION OF ALPHA-ENONES BY SODIUM-BOROHYDRIDE IN THE PRESENCE OF LANTHANOID CHLORIDES - SYNTHETIC AND MECHANISTIC ASPECTS [J].
GEMAL, AL ;
LUCHE, JL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1981, 103 (18) :5454-5459
[10]   A SEMIAUTOMATED MULTIPARAMETER APPROACH FOR ANTI-HIV DRUG SCREENING [J].
GULAKOWSKI, RJ ;
MCMAHON, JB ;
STALEY, PG ;
MORAN, RA ;
BOYD, MR .
JOURNAL OF VIROLOGICAL METHODS, 1991, 33 (1-2) :87-100